Quoin Pharmaceuticals/$QNRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Quoin Pharmaceuticals
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Ticker
$QNRX
Sector
Primary listing
Employees
5
Headquarters
Website
QNRX Metrics
BasicAdvanced
$9.5m
-
-$10.43
1.68
-
Price and volume
Market cap
$9.5m
Beta
1.68
52-week high
$41.80
52-week low
$3.25
Average daily volume
467k
Financial strength
Current ratio
2.868
Quick ratio
2.627
Long term debt to equity
17.938
Total debt to equity
24.777
Profitability
EBITDA (TTM)
-17.365
Management effectiveness
Return on assets (TTM)
-76.20%
Return on equity (TTM)
-231.18%
Valuation
Price to book
1.05
Price to tangible book (TTM)
1.1
Price to free cash flow (TTM)
-0.485
Free cash flow yield (TTM)
-206.10%
Free cash flow per share (TTM)
-9.707
Growth
Earnings per share change (TTM)
-73.89%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs